Home › Neuroblastoma › New York › New York City

Pag-aaral pangklinika para sa Neuroblastoma sa New York City, NY

Isang pag-aaral para sa Neuroblastoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa New York City. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome

Nagre-recruitObservasyonal na pag-aaral

Memorial Sloan Kettering Cancer Center, New York

Lahat ng edad · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT00588068

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Nagre-recruitPhase 3

Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York

Hanggang edad 30 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06172296

A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma

Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo

Memorial Sloan Kettering Cancer Center, New York

Lahat ng edad · Lahat ng kasarian · Na-update Set 30, 2026 · NCT04936529

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Nagre-recruitPhase 1/2

Memorial Sloan Kettering Cancer Center ( Site 1010), New York

6 Months – 25 Years · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06395103

N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

Nagre-recruitPhase 2

Memorial Sloan Kettering Cancer Center, New York

18 Months – 19 Years · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT06528496

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Nagre-recruitPhase 3

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York

365 Days – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Nagre-recruitPhase 1/2

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York

12 Months – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04851119

SPEARHEAD-3 Pediatric Study

Nagre-recruitPhase 1/2

Memorial Sloan Kettering Kids, New York

Edad 2 hanggang 21 · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05642455

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

Nagre-recruitPhase 2

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

Lahat ng edad · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT06057948

Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

Nagre-recruitPhase 2

Memorial Sloan Kettering Cancer Center, New York

Edad 1 pataas · Lahat ng kasarian · Na-update May 29, 2026 · NCT00107289

Pag-aaral para sa Neuroblastoma sa ibang lungsod

Iba pang pag-aaral sa New York City

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.